According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's current earnings are ยฃ0.13 Billion. In 2025 the company made an earning of ยฃ21.72 Million, an increase over its 2024 earnings that were of ยฃ18.22 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.